Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents
Status:
Completed
Trial end date:
2020-04-02
Target enrollment:
Participant gender:
Summary
Fatty liver disease is an increasing problem in overweight and obese young adults. The
purpose of this study is to test the effect of growth hormone on liver fat in obese young
adults ages 18-29y with increased liver fat.